Creative Planning Abbott Laboratories Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

A detailed history of Creative Planning transactions in Abbott Laboratories stock. As of the latest transaction made, Creative Planning holds 808,863 shares of ABT stock, worth $104 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
808,863
Previous 765,471 5.67%
Holding current value
$104 Million
Previous $79.5 Million 15.94%
% of portfolio
0.09%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$100.07 - $118.13 $4.34 Million - $5.13 Million
43,392 Added 5.67%
808,863 $92.2 Million
Q2 2024

Aug 15, 2024
SELL
$100.73 - $112.44 $1.23 Million - $1.38 Million
-12,239 Reduced 1.57%
765,471 $79.5 Million
Q1 2024

May 10, 2024
BUY
$109.52 - $120.96 $2.84 Million - $3.14 Million
25,938 Added 3.45%
777,710 $88.4 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $5.54 Million - $6.78 Million
-61,450 Reduced 7.56%
751,772 $82.7 Million
Q3 2023

Nov 16, 2023
BUY
$95.53 - $114.62 $14.4 Million - $17.2 Million
150,312 Added 22.67%
813,222 $78.8 Million
Q2 2023

Jul 21, 2023
BUY
$100.78 - $112.29 $1.84 Million - $2.05 Million
18,249 Added 2.83%
662,910 $72.3 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $702,138 - $826,458
-7,249 Reduced 1.11%
644,661 $65.3 Million
Q4 2022

Feb 10, 2023
BUY
$95.06 - $111.52 $5.44 Million - $6.39 Million
57,264 Added 9.63%
651,910 $71.6 Million
Q3 2022

Nov 03, 2022
SELL
$96.76 - $112.03 $392,168 - $454,057
-4,053 Reduced 0.68%
594,646 $57.5 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $2.97 Million - $3.58 Million
29,050 Added 5.1%
598,699 $65 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $19.5 Million - $23.8 Million
171,234 Added 42.98%
569,649 $67.4 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $1.8 Million - $2.21 Million
15,597 Added 4.07%
398,415 $56.1 Million
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $235,769 - $260,830
2,021 Added 0.53%
382,818 $45.2 Million
Q2 2021

Aug 04, 2021
SELL
$105.79 - $124.53 $4.16 Million - $4.89 Million
-39,300 Reduced 9.35%
380,797 $44.1 Million
Q1 2021

Apr 30, 2021
BUY
$108.84 - $128.23 $688,521 - $811,182
6,326 Added 1.53%
420,097 $50.3 Million
Q4 2020

Jan 29, 2021
BUY
$105.0 - $114.42 $574,560 - $626,106
5,472 Added 1.34%
413,771 $45.3 Million
Q3 2020

Nov 05, 2020
BUY
$91.64 - $111.29 $1.54 Million - $1.87 Million
16,802 Added 4.29%
408,299 $44.4 Million
Q2 2020

Jul 23, 2020
BUY
$76.57 - $98.0 $2.24 Million - $2.86 Million
29,231 Added 8.07%
391,497 $35.8 Million
Q1 2020

May 05, 2020
BUY
$62.82 - $91.86 $344,002 - $503,025
5,476 Added 1.53%
362,266 $28.6 Million
Q4 2019

Jan 30, 2020
SELL
$78.51 - $87.4 $227,286 - $253,023
-2,895 Reduced 0.8%
356,790 $31 Million
Q3 2019

Nov 01, 2019
SELL
$81.84 - $88.74 $242,573 - $263,025
-2,964 Reduced 0.82%
359,685 $30.1 Million
Q2 2019

Jul 26, 2019
BUY
$72.88 - $85.0 $1.96 Million - $2.29 Million
26,954 Added 8.03%
362,649 $30.5 Million
Q1 2019

Apr 24, 2019
BUY
$66.22 - $80.06 $1.61 Million - $1.94 Million
24,281 Added 7.8%
335,695 $26.8 Million
Q4 2018

Feb 01, 2019
BUY
$65.56 - $74.27 $408,832 - $463,147
6,236 Added 2.04%
311,414 $22.5 Million
Q3 2018

Oct 25, 2018
BUY
$60.81 - $73.36 $879,738 - $1.06 Million
14,467 Added 4.98%
305,178 $22.4 Million
Q2 2018

Jul 20, 2018
BUY
$57.57 - $63.54 $719,164 - $793,741
12,492 Added 4.49%
290,711 $17.7 Million
Q1 2018

Apr 18, 2018
BUY
$56.27 - $63.62 $605,746 - $684,869
10,765 Added 4.02%
278,219 $16.7 Million
Q4 2017

Jan 17, 2018
BUY
$53.68 - $57.47 $1.68 Million - $1.8 Million
31,370 Added 13.29%
267,454 $15.3 Million
Q3 2017

Oct 17, 2017
BUY
$48.06 - $53.64 $11.3 Million - $12.7 Million
236,084
236,084 $12.6 Million

Others Institutions Holding ABT

# of Institutions
3,228
Shares Held
1.3B
Call Options Held
8.71M
Put Options Held
8.03M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email